22.418 articles found

Methods and compositions for the treatment and prevention of parkinson's disease

RUEGER DAVID C, SAMPATH KUBER T, COHEN CHARLES M, OPPERMANN HERMANN, PANG ROY H L.

· 2002-10-16

BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES.

LEI HUANGSHU.

· 2002-10-16

Evidence-based medicine (EBM) applied to Parkinson's disease treatment.

Sampaio C, Ferreira JJ, Costa J.

Parkinsonism Relat Disord · 2002-10-01

DOI: 10.1016/s1353-8020(02)00039-1PMID: 12217617

Treatment of advanced stage patients with Parkinson's disease.

Waters CH.

Parkinsonism Relat Disord · 2002-10-01

DOI: 10.1016/s1353-8020(02)00040-8PMID: 12217618

Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application.

Bonifácio MJ, Archer M, Rodrigues ML, Matias PM, Learmonth DA, Carrondo MA, Soares-Da-Silva P.

Mol Pharmacol · 2002-10-01

DOI: 10.1124/mol.62.4.795PMID: 12237326

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

Brundin P.

Brain · 2002-10-01

DOI: 10.1093/brain/awf217PMID: 12244075

Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.

Hilker R, Voges J, Thiel A, Ghaemi M, Herholz K, Sturm V, Heiss WD.

J Neural Transm (Vienna) · 2002-10-01

DOI: 10.1007/s00702-002-0696-5PMID: 12373559

Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.

Klintenberg R, Svenningsson P, Gunne L, Andrén PE.

J Neural Transm (Vienna) · 2002-10-01

DOI: 10.1007/s00702-002-0715-6PMID: 12373562

Cellular replacement therapy for Parkinson's disease--where we are today?

Redmond DE.

Neuroscientist · 2002-10-01

DOI: 10.1177/107385802237703PMID: 12374430

Mitochondrial therapy for Parkinson disease.

Rosenberg RN.

Arch Neurol · 2002-10-01

DOI: 10.1001/archneur.59.10.1523PMID: 12374488

Subthalamic GAD gene therapy in a Parkinson's disease rat model.

Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ.

Science · 2002-10-01

DOI: 10.1126/science.1074549PMID: 12376704

Antioxidants as treatment for neurodegenerative disorders.

Moosmann B, Behl C.

Expert Opin Investig Drugs · 2002-10-01

DOI: 10.1517/13543784.11.10.1407PMID: 12387703